e2-Capital makes strides in building biotech business

e2-Capital wins three mandates to provide advisory and fundraising services to Chinese biotech projects.
November 30, 2000

Five months after announcing plans to develop a biotechnology business, Hong Kong-based technology banking group e2-Capital is beginning to put its money where its mouth is.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media